Converting Cold into Hot Tumors by Combining Immunotherapies.
Cell
; 170(6): 1055-1056, 2017 09 07.
Article
en En
| MEDLINE
| ID: mdl-28886376
ABSTRACT
In a small phase Ib study in this issue of Cell, Ribas et al. report that the combination of intralesional injection of a modified human herpes simplex virus and systemic anti-PD-1 treatment resulted in a 62% response rate in patients with metastatic melanoma, accompanied by enhanced T cell infiltration in virus-injected lesions.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Inmunoterapia
/
Melanoma
Límite:
Humans
Idioma:
En
Revista:
Cell
Año:
2017
Tipo del documento:
Article